In July 2013, Cubist Pharmaceuticals agreed to purchase Trius Therapeutics and Optimer Pharmaceuticals for around $1.6 billion.
Trius Therapeutics | The Medical Letter on Drugs and Therapeutics | Journal of Pharmacology and Experimental Therapeutics | Journal of Manipulative and Physiological Therapeutics | Esperion Therapeutics | Acorda Therapeutics |